Evidence map›Paper›PMID 36865679›Full record

ArticleContemporary clinical trials communications2023

Effect of

Wenjun Liu, Nong-Hua Lu, Xu Zhou, Yingmeng Li, Yong Xie, Longjin Zheng, Weifeng Zhu, Qiuping Xiao, Ni Yang, Kexuan Zuo and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Contemporary clinical trials communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Wenjun LiuKey Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Key Laboratory of Dairy Products Processing, Ministry of Agriculture and Rural Affairs, Inner Mongolia Key Laboratory of Dairy Biotechnology and Engineering, Inner Mongolia Agricultural University, Hohhot, 010018, China.
Nong-Hua LuDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
Xu ZhouEvidence Based Medicine Research Center, Jiangxi University of Chinese Medicine, Nanchang, 330004, China.
Yingmeng LiState Key Laboratory of Innovative Medicines and High-efficiency Energy-saving Pharmaceutical Equipment, Nanchang, 330006, China.
Yong XieDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
Longjin ZhengState Key Laboratory of Innovative Medicines and High-efficiency Energy-saving Pharmaceutical Equipment, Nanchang, 330006, China.
Weifeng ZhuEvidence Based Medicine Research Center, Jiangxi University of Chinese Medicine, Nanchang, 330004, China.
Qiuping XiaoState Key Laboratory of Innovative Medicines and High-efficiency Energy-saving Pharmaceutical Equipment, Nanchang, 330006, China.
Ni YangState Key Laboratory of Innovative Medicines and High-efficiency Energy-saving Pharmaceutical Equipment, Nanchang, 330006, China.
Kexuan ZuoState Key Laboratory of Innovative Medicines and High-efficiency Energy-saving Pharmaceutical Equipment, Nanchang, 330006, China.
Tielong XuEvidence Based Medicine Research Center, Jiangxi University of Chinese Medicine, Nanchang, 330004, China.
Heping ZhangKey Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Key Laboratory of Dairy Products Processing, Ministry of Agriculture and Rural Affairs, Inner Mongolia Key Laboratory of Dairy Biotechnology and Engineering, Inner Mongolia Agricultural University, Hohhot, 010018, China.
Shanghai Innovative Research Center of Traditional Chinese Medicine · CNJiangxi University of Traditional Chinese Medicine · CNInner Mongolia Agricultural University · CNNanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Probiotics may be an ideal choice for these patients, given it can improve the defecation and quality of life of individuals with chronic diarrhoea. However, evidence-based medical research is still limited to support its use as a diarrhoea agent. Method: A randomized, double-blind, placebo-controlled clinical trial is designed to pinpoint the efficiency and possible action modes of probiotics for chronic diarrhoea. 200 eligible volunteers with chronic diarrhoea are randomly assigned to a probiotic group (orally taking Discussion: The study protocol will provide high-quality evidence for the use of probiotics as a diarrhoea agent when it is strictly conducted out, providing evidence regarding whether and to what extent Trial registration: Chinese Clinical Trial Registry (ChiCTR) (NO. ChiCTR2000038410). Registered on November 22, 2020, https://www.chictr.org.cn/showproj.aspx?proj=56542.

Indexed as

Chronic diarrhoeaClinical trialEffectivenessLactobacillus plantarumProbiotics

Identifiers

PMID36865679
PMCPMC9970898
OpenAlexW4318827554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.